基本信息
姓名：李煦照
职称：教授
专业：中药学
研究方向：中药药理学、中药分析学、分子印迹技术
开设课程：《中药药性学专论》
全职工作单位：贵州中医药大学
电子邮箱：xuzhaoli@vip.163.com
个人简介
李煦照，男，教授，博士生导师，贵州省“千层次”创新型人才，中药学学科学术骨干，中华中医药学会中药基础理论分会委员。获得国家自然科学基金项目2项；贵州省基础研究计划项目1项。获得2024年Wiley China Excellent Author Program Award（Wiley中国高贡献作者奖）。近五年发表中文核心期刊论文10篇；发表SCI论文24篇。为多个SCI杂志的审稿人。
科研项目
1.运用系统药理学方法探索追风伞对关节滑膜疾病的治疗潜能及相关机制，国家自然科学基金-地区科学基金项目，81760784，2018.01-2021.12，34万元，已结题，主持；
2.运用生物标签研究模式多维度探索杜仲叶治疗中枢神经系统疾病的分子机制，国家自然科学基金-地区科学基金项目，82060725，2021.01-2024.12，33万元，已结题，主持；
3.杜仲叶抗癫痫的活性成分的分子印迹纳米核壳微球的制备及作用机制研究，贵州省科技计划项目，黔科合基础-ZK[2024]一般378，2024.4.1-2027.3.31，10万元，在研，主持；
代表性论文
1.Qian-qian Shao, Shuai-nan Zhang,Xu-zhao Li.Pathogenesis of osteoarthritis and treatment with traditional Chinesemedicine: New perspectives on platelet aggregation.International Immunopharmacology, 2025,167:115665.(中科院二区，IF=4.7，通讯作者)
2.Si-hui YANG, Shuai-nan ZHANG,Xu-zhao LI.Advances in Therapeutic Targets and Traditional Chinese Medicine for Cardiomyopathy.Phytotherapy Research,2025,39(6):2641-2671. (中科院二区，IF=6.3，通讯作者)
3.Yi-zhen SUN, Ying ZHOU,Xu-zhao LI, Shuai-nan ZHANG.Recent advances in the application of nanomaterials for separation and enrichments of small molecule active ingredients of traditional Chinese medicine.Microchemical Journal,2024, 207:111827. (中科院二区，IF=4.9，TOP期刊，通讯作者)
4.Shuai-Nan Zhang, Qi Liu,Xu-Zhao Li, Wu-De Yang, Ying Zhou.Liver protein and metabolite biolabels reveal hepatoprotective effects and active compounds of Eucommiae folium: Exploration of new application of herb based on multi-omics and bioinformatics.Journal of Pharmaceutical and Biomedical Analysis,2024, 239, 115870.(中科院三区，IF=3.1，通讯作者)
5.Shuai-Nan Zhang, Qi Liu,Xu-Zhao Li, Wu-De Yang, Ying Zhou.Sophora tonkinensisand active compounds inhibit mitochondrial impairments, inflammation, and LDLR deficiency in myocardial ischemia mice through regulating the vesicle-mediated transport pathway.Fitoterapia,2024,172, 105756.(中科院三区，IF=2.5，通讯作者)
6.Shuai-nan Zhang, Qi Liu,Xu-zhao Li, Wu-de Yang, Ying Zhou.Cardioprotection of Eucommiae Folium: the extract and pharmaceutically active compounds attenuate hyperglycemia, mitochondrial dysfunction, calcium dyshomeostasis, insulin resistance, and oxidative stress in diabetic cardiomyopathy db/db mice.Journal of Pharmacy and Pharmacology,2023,75, 1509-1520.(中科院三区，IF=2.8，通讯作者)
7.Shuai-nan Zhang, Hong-mei Li, Qi Liu,Xu-zhao Li, Wu-de Yang, Ying Zhou.Eucommiae Folium and active compounds protect against mitochondrial dysfunction-calcium overload in epileptic hippocampal neurons through the hypertrophic cardiomyopathy pathway.Neurochemical Research,2023,48, 2674-2686.(中科院三区，IF=4.4，通讯作者)
8.Shuai-nan Zhang, Ya-feng He,Xu-zhao Li, Wu-de Yang, Ying Zhou.Biolabel-led research pattern positions the effects and mechanisms of Sophorae Tonkinensisradix et rhizome on lung diseases: A novel strategy for computer-aided herbal medicine research based on omics and bioinformatics.Computers in Biology and Medicine,2021, 136: 104769.(中科院二区，IF=4.589，通讯作者)
9.Shuai-nan Zhang,Xu-zhao Li, Wu-de Yang, Ying Zhou. Sophorae Tonkinensis radix et rhizome-induced pulmonary toxicity: A study on the toxic mechanism and material basis based on integrated omics and bioinformatics analyses.Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences,2021, 1179:122868.(中科院三区，IF=3.205，通讯作者)
10.Shuai-nan Zhang, Hong-mei Li,Xu-zhao Li, Wu-de Yang, Ying Zhou. Integrated omics and bioinformatics analyses for the toxic mechanism and material basis ofSophorae Tonkinensis radix et rhizome-induced hepatotoxicity.Journal of Pharmaceutical and Biomedical Analysis,2021, 198:113994.(中科院二区，IF=3.209，通讯作者)
获奖：
1.Wiley China Excellent Author Program Award（Wiley中国高贡献作者奖），2024.
专著/教材：
1.编委，《临床中药学》，人民卫生出版社，2021年5月，“十四五”规划教材；
2.编委，《临床中药学》，中国医药科技出版社，2024年1月，“十四五”规划教材；
